Millions of people with Medicare will soon be eligible to get discounted GLP-1 drugs for weight loss. Here's how it will work ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
Starting July 2026, Medicare will pilot the 'GLP-1 Bridge,' a temporary program allowing some retirees coverage for weight loss drugs like Wegovy and Zepbound. The initiative marks a shift from ...
Centers for Medicare and Medicaid Services COO Kim Brandt talked about her agency’s use cases for artificial intelligence in the ongoing battle against fraudulent medical claims. The Centers for ...
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
Congress has an obligation to direct the Centers for Medicare and Medicaid Services to partner with state Medicaid leaders ...
The Centers for Medicare & Medicaid Services announced a seven-prong update to the Civil Money Penalty Reinvestment Program on Monday. The agency has increased the project funding cap by 20% and also ...
The Centers for Medicare and Medicaid Services recently announced negotiated prices for 15 drugs, finalizing the second iteration of the Medicare Drug Price Negotiation Program. The first set of ...
The Trump administration decided to put the pilot on hold until at least 2027.
The White House said Monday afternoon that it will extend the deadline for drugmakers to apply for a new model that seeks to establish most-favored nation pricing in Medicaid. The Centers for Medicare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results